Article
Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.
Journal of neurology, neurosurgery, and psychiatry - 1 Dec 2004
Helisalmi S, Hiltunen M, Vepsäläinen S, Iivonen S, Mannermaa A, Lehtovirta M, Koivisto A M, Alafuzoff I, Soininen H
Abstract excerpt
OBJECTIVES: Neprilysin (NEP) is an amyloid beta-peptide (Abeta) degrading enzyme expressed in the brain, and accumulation of Abeta is the neuropathological hallmark in Alzheimer's disease (AD). In this study we investigated whether polymorphisms in the NEP gene have an effect on the risk for AD. METHODS: The frequencies of seven single nucleotide polymorphisms (SNPs) and apolipoprotein E (APOE) were assessed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
